Nerve Growth Factor and Its Monocyte Receptors Are Affected in Kidney Disease

Publisher： Karger

E-ISSN： 1660-2110|111|1|c21-c28

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.111, Iss.1, 2008-12, pp. : c21-c28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A prospective study of fibroblast growth factor-23 in children with chronic kidney disease

By Magnusson Per Hansson Sverker Swolin-Eide Diana

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 70, Iss. 1, 2010-02 ,pp. : 15-20

Informa Healthcare

Access to resources Recommend Favorite

Fibroblast Growth Factor 23/Klotho Axis in Chronic Kidney Disease

Nephron Clin Pract, Vol. 128, Iss. 1-2, 2014-11 ,pp. : 1-10

Karger

Access to resources Recommend Favorite

Nerve Growth Factor: Neurotrophin or Cytokine?

International Archives of Allergy and Immunology, Vol. 131, Iss. 2, 2009-07 ,pp. : 80-84

Karger

Access to resources Recommend Favorite

Is Fibroblast Growth Factor-23 a novel marker for phosphate burden in chronic kidney disease with prognostic implications?

By Bielesz Bernhard

Wiener klinische Wochenschrift, Vol. 122, Iss. 7-8, 2010-04 ,pp. : 194-197

Springer Publishing Company

Access to resources Recommend Favorite

Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease

By Manghat P. Fraser W. Wierzbicki A. Fogelman I. Goldsmith D. Hampson G.

Osteoporosis International, Vol. 21, Iss. 11, 2010-11 ,pp. : 1853-1861

Springer Publishing Company

Access to resources Recommend Favorite